Crohn’s disease

Crohn’s & Colitis Foundation selected for FDA MyStudies app project

The Crohn’s & Colitis Foundation was selected as one of two patient organizations to participate in an U.S. Food & Drug Administration (FDA) Real-World Evidence Program demonstration project using the FDA MyStudies App through the FDA-Catalyst system. The FDA Real World Evidence Program will inform the assessment of the fitness for use of real-world data to support real-world evidence generation for ...

Read More »

Crohn’s disease study identifies genetic variant with potential to personalize treatment

The largest study ever to look at why an expensive and commonly–used group of drugs fails some patients with Crohn’s disease has identified a genetic marker which could individualize drug treatment. A UK wide collaboration led by the University of Exeter, Royal Devon & Exeter NHS Foundation Trust and the Wellcome Sanger Institute, has demonstrated that a genetic variant carried by 40% of the ...

Read More »